Mechanical Circulatory Support
Preventive medicine and care integrate various health interventions aimed at reducing the risk of illness, injury, and disease. One of the critical aspects of preventive healthcare is managing and preventing the onset and progression of cardiovascular diseases. Mechanical circulatory support (MCS) is one such intervention that supports patients with advanced heart failure before and after heart transplant surgery. MCS is a technology that assists the heart to pump blood throughout the body in patients with advanced heart failure. This treatment approach aims at stabilizing the patient’s condition by increasing blood flow, reducing the workload on the heart and allowing the heart muscles to recover. MCS is an alternative to heart transplant surgery for patients who are not considered suitable candidates. MCS includes various devices, each designed to support the different parts of the heart. For instance, the ventricular assist device (VAD) assists the left or right ventricle, while total artificial heart (TAH) takes on the role of both ventricles. Some of the other devices that comprise MCS include extracorporeal membrane oxygenation (ECMO), intra-aortic balloon pump (IABP), and temporary pacing wires. MCS has revolutionized the field of cardiovascular medicine and has significantly impacted the treatment and management of advanced heart failure. This advanced technology has improved patient outcomes and has prolonged the life of many patients while awaiting heart transplant surgery. In conclusion, mechanical circulatory support is a critical aspect of preventive medicine and care, as it provides life-saving support to patients with advanced heart failure. The use of MCS has improved the quality of life of patients with heart failure and reduced mortality rates. The integration of this technology into cardiovascular medicine has expanded the scope of care, ensuring that patients have access to the latest treatments and interventions.
← Journal of Preventive Medicine And Care